Oriza Seed Capital (Oriza Yuandian)
VC Fund
Suzhou, China
Oriza Seed Capital (Oriza Yuandian) is a VC fund in Suzhou focused on Manufacturing and Health Care. Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcare field. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
- Total investments:
- 154
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Oriza Seed Capital (Oriza Yuandian) invests in
Stages Oriza Seed Capital (Oriza Yuandian) invests in
Countries Oriza Seed Capital (Oriza Yuandian) invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $223k–$25M
- Angel
- $425k–$15M
- Series A
- $1.4M–$60M
Investment Focus
Industry
- Manufacturing 24 (16%)
- Health Care 21 (14%)
- Medical 15 (10%)
- Biotechnology 14 (9%)
- Information Technology 8 (5%)
Stage
- Series A 47 (31%)
- Seed 38 (25%)
- Angel 27 (18%)
- Series B 14 (9%)
- Series C 7 (5%)
Country
- China 106 (69%)
- United States 5 (3%)
- Singapore 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Fei Jianjiang
Founder,General Manager & Managing Partner
|
Founder,General Manager & Managing Partner | Total investments: 0 | Find email | |
|
Grace Yang
Partner
|
Partner | Total investments: 0 | Find email | |
|
Jiang Mingda
Partner
|
Partner | Total investments: 3 | Find email | |
Kong Lingguo
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 0 | Find email | |
|
Zang Xiaojie
Investment Director
|
Investment Director | Total investments: 1 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Weilan Deep-Sea
|
Weilan Deep-Sea focuses on the global underwater ocean observation field, with its core product being distributed underwater observation systems that integrate advanced sensing, data transmission, and intelligent monitoring technologies to enable long-term, wide-area, and high-precision observation of oceanographic, environmental, and geologicalprocesses. | Angel / Oct 08, 2026 | |
|
Diver Innovation
|
Loon Innovation addresses a key limitation of traditional unmanned systems they typically operate in isolation, with aerial drones (“fly in the sky”) and underwater vehicles (“swim in the water”) functioning independently rather than as an integrated, coordinated system. | $1.5M / Angel / Sep 22, 2026 | |
Thortime Technology
|
Thortime Technology is a hard-tech company specializing in the full-stack development, manufacturing, and delivery of Neutral Beam Injection systems for controllable nuclear fusion devices. | $14.9M / Angel / Aug 25, 2026 | |
| Navi Therapeutics is a biotechnology company focused on developing next-generation antibody-drug conjugates and antibody-based therapeutics for oncology | Series A / Aug 18, 2026 | ||
|
Youshu Quantum
|
Youshu Quantum is a deep-tech startup specializing in quantum computing software, middleware, and proprietary algorithms. | Seed / Aug 03, 2026 | |
| Jitian Xingzhou is a commercial aerospace company that provides optical main payloads in batches as one of its primary operations. | Series B / Jun 25, 2026 | ||
|
DeepDome
|
DeepDome is a service provider specializing in research and experimental development, delivering innovative solutions through systematic investigation, advanced methodologies, and applied scientific expertise. | Angel / Jun 23, 2026 | |
|
Jiangxian Technology
|
Jiangxian Technology is a company focused on embodied intelligence, a field that integrates artificial intelligence with physical systems such as robots and smart devices, enabling machines to perceive, learn from, and interact with the real world in a more human-like and adaptive manner across applications like automation, healthcare, and advancedmanufacturing. | Seed / Jun 11, 2026 | |
| OriginFlow develops NeuroScale, a non‑invasive embodied intelligence platform that uses a motor neural interface and proprietary hardware/software to capture surface EMG signals. Their PULSE model encodes sEMG to accurately reconstruct continuous multimodal information hand posture, force, and tactile feedback without visual input. Thisapproach removes asynchronous data errors, overcomes EgoScale limitations and enables a seamless “shadow mode” for embodied intelligence. | $73.5M / Seed / May 21, 2026 | ||
| Eagle Vision Intelligent Technology focuses on pioneering research in embodied intelligence and flapping-wing flight technologies, aiming to develop advanced bio-inspired robotic systems that integrate perception, cognition, and motion to achieve highly efficient, adaptive, and agile aerial platforms for applications ranging from environmentalmonitoring to next-generation autonomous flight. | Seed / May 08, 2026 | ||
| See all 154 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Oriza Seed Capital (Oriza Yuandian) invest in?
Oriza Seed Capital (Oriza Yuandian) invests primarily in Manufacturing, Health Care and Medical startups, most often at Series A and Seed stage. Most of the 154 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Oriza Seed Capital (Oriza Yuandian) invest in?
Oriza Seed Capital (Oriza Yuandian) typically joins rounds of $223k–$25M at Seed, $425k–$15M at Angel and $1.4M–$60M at Series A. These are whole funding-round sizes, not Oriza Seed Capital (Oriza Yuandian)'s own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Oriza Seed Capital (Oriza Yuandian) took part in.
How do I contact Oriza Seed Capital (Oriza Yuandian)?
Public channels for Oriza Seed Capital (Oriza Yuandian) include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oriza Seed Capital (Oriza Yuandian)?
The team at Oriza Seed Capital (Oriza Yuandian) includes Fei Jianjiang (Founder,General Manager & Managing Partner), Grace Yang (Partner) and Jiang Mingda (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
